
Yan HUANG1, Jialin YE1, Lan XU1, Xingjie HU2, Nan CHEN1. Dual-functional nanoplatform for simultaneous degradation of circRNA CDR1as and real-time monitoring of miR-7 in live cells[J]. Journal of Zhejiang University Science B, 1998, -1(-1): .
@article{title="Dual-functional nanoplatform for simultaneous degradation of circRNA CDR1as and real-time monitoring of miR-7 in live cells",
author="Yan HUANG1, Jialin YE1, Lan XU1, Xingjie HU2, Nan CHEN1",
journal="Journal of Zhejiang University Science B",
volume="-1",
number="-1",
pages="",
year="1998",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B2500787"
}
%0 Journal Article
%T Dual-functional nanoplatform for simultaneous degradation of circRNA CDR1as and real-time monitoring of miR-7 in live cells
%A Yan HUANG1
%A Jialin YE1
%A Lan XU1
%A Xingjie HU2
%A Nan CHEN1
%J Journal of Zhejiang University SCIENCE B
%V -1
%N -1
%P
%@ 1673-1581
%D 1998
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B2500787
TY - JOUR
T1 - Dual-functional nanoplatform for simultaneous degradation of circRNA CDR1as and real-time monitoring of miR-7 in live cells
A1 - Yan HUANG1
A1 - Jialin YE1
A1 - Lan XU1
A1 - Xingjie HU2
A1 - Nan CHEN1
J0 - Journal of Zhejiang University Science B
VL - -1
IS - -1
SP -
EP - 0
%@ 1673-1581
Y1 - 1998
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B2500787
Abstract: circular RNAs (circRNAs) are key post-transcriptional regulators with critical roles in pathogenesis, yet existing tools for their precise manipulation and functional analysis in living cells remain to be developed. A compelling therapeutic target in this field is the circRNA cerebellar degeneration-related protein 1 antisense (CDR1as), functioning as an oncogenic sponge for microRNA-7 (miR-7). Herein, we report a novel multifunctional the Zeolitic Imidazolate Framework-8 (ZIF-8)-based nanoplatform for the simultaneous disruption and real-time monitoring of the CDR1as/miR-7 regulatory axis. This system, named as DZ/MB@ZIF-8, co-encapsulates a designed set of DNAzymes for the catalytic cleavage of CDR1as as well as a molecular beacon (MB) for reporting on miR-7 activity. Following cellular uptake and lysosomal trafficking, the acidic microenvironment triggers nanoplatform disassembly, concurrently releasing the therapeutic and sensing components along with essential Zn2+ cofactors for DNAzyme activation. This system demonstrates efficient CDR1as degradation, which liberates miR-7 and inhibits the expression of its downstream oncogenic targets. Crucially, this therapeutic effect is directly correlated with a turn-on fluorescent signal from the MB, enabling the real-time, live-cell readout of circRNA regulation. This work establishes a versatile theranostic strategy that merges targeted gene regulation with intrinsic biosensing, offering a powerful platform for probing circRNA function and advancing RNA-based therapeutics.
CLC number:
On-line Access: 2026-05-07
Received: 2025-12-01
Revision Accepted: 2026-04-08
Crosschecked: 0000-00-00
Cited: 0
Clicked: 15
Open peer comments: Debate/Discuss/Question/Opinion
<1>